Ftse Mib
33.772,39
-0,04%
DAX
19.884,75
-0,57%
S&P 500
5.971,39
1,78%
NASDAQ
19.732,57
1,86%
Bitcoin
96.629,05
-0,85%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Teva Pharmaceutical Industries Ltd (TEVA) Teva Pharmaceutical Industries Ltd (TEVA) Notizie

Teva Pharmaceutical Industries Ltd

TEVA
21,9005
0,5905 (2,77%)
Ultimo aggiornamento: 17:43:30
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/12/202413:30GLOBETeva and Sanofi Announce Duvakitug (Anti-TL1A) Positive..
11/12/202414:00GLOBETeva Announces New Patient Access Program with Direct Relief..
06/12/202400:00GLOBETeva Announces Agreement to Divest Teva-Takeda, its Business..
04/12/202408:00GLOBETeva Presents Positive Efficacy and Safety Data of AJOVY®..
26/11/202400:00GLOBETeva to Present at the 7th Annual Evercore ISI HealthCONx..
21/11/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202417:39EDGAR2Form 144 - Report of proposed sale of securities
08/11/202422:30GLOBETeva to Present at the Jefferies London Healthcare..
06/11/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202413:00EDGAR2Form 8-K - Current report
06/11/202413:00GLOBETeva Announces Strong Financial Results for the Third..
06/11/202412:12IHMARKETNEWSU.S. Index Futures Surge on Trump Victory Prospects;..
01/11/202420:05GLOBETeva Presents New Tardive Dyskinesia Data at Psych Congress..
01/11/202420:00GLOBETeva Presents Latest Schizophrenia Treatment Research,..
31/10/202412:29GLOBETeva Statement on European Commission Decision; Company to..
22/10/202413:00GLOBEAlvotech and Teva Announce U.S. FDA Approval of Additional..
11/10/202412:31IHMARKETNEWSBP Signals Rising Net Debt; Tesla Slumps; Stellantis CEO..
08/10/202413:00GLOBETeva Prolia® (Denosumab) Biosimilar Candidate is Accepted..
03/10/202414:30GLOBETeva and mAbxience Expand Strategic Partnership to include..
01/10/202414:29GLOBETeva Announces Launch of the First and Only Generic Version..
30/9/202422:30GLOBETeva to Host Conference Call to Discuss Third Quarter 2024..
23/9/202407:00GLOBETeva Announces Long Term Efficacy and Safety of..
21/9/202410:15GLOBETeva Presents New Phase 3 Efficacy, Safety and Tolerability..
21/9/202410:10GLOBENew Data Provide Treatment Insights into Options for..
11/9/202422:30GLOBETeva to Present at the Bank of America 2024 Global..
11/9/202412:25IHMARKETNEWSGameStop plunges 11% on stock offering, DJT drops..
04/9/202413:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202423:00GLOBETeva to Present at the Morgan Stanley 22nd Annual Global..
14/8/202413:06EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
13/8/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202421:59EDGAR2Form 144 - Report of proposed sale of securities
31/7/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202413:00EDGAR2Form 8-K - Current report
31/7/202413:00GLOBETeva Announces Strong Growth in Second Quarter Revenues..
31/7/202412:01IHMARKETNEWSUS Index Futures Up Ahead of Fed Decision; Oil Prices Surge..
25/7/202407:30BWTeva and Sanofi Announce Accelerated Timeline for Anti-TL1A..
18/7/202414:30BWTeva Announces First Phase 3 Evidence of Efficacy and Safety..
03/7/202400:00BWTeva to Host Conference Call to Discuss Second Quarter 2024..
29/6/202400:34BWLes nouvelles données portant sur AJOVY® (fremanezumab) dans..
28/6/202421:41BWNeue Daten zu AJOVY® (Fremanezumab) zur Migräneprävention..
28/6/202417:30BWNew AJOVY® (fremanezumab) Migraine Prevention Data..
25/6/202414:00BWTeva Reaches Agreement With the Israel Tax Authority to..
24/6/202415:50BWTeva Announces Launch of Authorized Generic of Victoza®..
17/6/202414:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202414:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202413:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202413:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202413:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 21,16 Min: 21,11 Max: 21,935
Chiusura: 21,31

La tua Cronologia

NYSE
TEVA
Teva Pharmaceutical Indu...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network